Download PDF
Arzneimittelforschung 2010; 60(6): 336-339
DOI: 10.1055/s-0031-1296297
Antibiotics · Antimycotics · Antiparasitics · Antiviral Drugs · Chemotherapeutics · Cytostatics
Editio Cantor Verlag Aulendorf (Germany)

Development of an analytical method for cefpirome in plasma by simplified HPLC technique and its applications

Somchai Sriwiriyajan
Department of Pharmacology, Faculty of Science, Prince of Songkla University, Songkhla, Thailand
,
Werawath Mahatthanatrakul
Department of Pharmacology, Faculty of Science, Prince of Songkla University, Songkhla, Thailand
› Author Affiliations
Further Information

Publication History

Publication Date:
02 December 2011 (online)

    Permissions and Reprints

Abstract

The objective of this study was to develop a rapid and simplified, reliable high-performance liquid chromatography (HPLC) method for quantification of cefpirome (CAS 98753-19-6) in plasma. After precipitation of the plasma containing the internal standard, hydrochlorothiazide, with 5 % trichloroacetic acid (TCA), the analysis of the cefpirome level in the plasma samples was carried out using a reverse-phase C18 column with the ultraviolet detector set at a wavelength of 258 nm. The chromatographic separation was accomplished with an isocratic mobile phase consisting of acetonitrile-acetate buffer pH 5. The proposed method was specific and sensitive with a lower limit of quantitation (LLOQ) of 0.5 μg/ml. This HPLC method was validated by examining the precision and accuracy for inter- and intra-day analysis in the concentration range 0.5–64.0 μg/ml. The relative standard deviation in the inter-and intra-day validation was less than 3 %. Analytical recovery was more than 84 %, and cefpirome was found to be stable in human plasma during both the storage and assay procedures. A satisfactory pharmacokinetic study of cefpirome was carried out in rabbits using the devised procedure.

Key words

CAS 98753-19-6 - Cefpirome, pharmacokinetics, quantification in plasma - Cephalosporin antibiotic - HPLC
 

  • References

  • 1 Wiseman LR, Lamb HM. Cefpirome. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy in the treatment of severe nosocomial infections and febrile neutropenia. Drugs. 1997; 54: 117-40
    CrossrefPubMedGoogle Scholar
  • 2 Bawdon RE, Lu YS, Brater DC. High-pressure liquid chromatographic assay and pharmacokinetics of HR 810 after intramuscular injection in rabbits. Antimicrob Agents Chemother. 1985; 27: 436-8
    CrossrefPubMedGoogle Scholar
  • 3 Uihlein M, Klesel N, Seeger K. Determination of cefpirome (HR 810) in serum and urine. Infection. 1988; 16: 135-40
    PubMedGoogle Scholar
  • 4 Turley CP, Kearns GL, Jacobes RF. Microanalytical high-performance liquid chromatography assay for cefpirome (HR 810) in serum. Antimicrob Agents Chemother. 1988; 32: 1481-3
    CrossrefPubMedGoogle Scholar
  • 5 Kearns GL, Jhonson VA, Hendry IR, Well TG. Microanalytical high-performance liquid chromatographic assay for cefpirome in human milk and urine. J Chromatogr. 1992; 574: 356-60
    CrossrefPubMedGoogle Scholar
  • 6 Breilh D, Lavallee C, Fratta A, Ducint D, Cony-Makhoul P, Saux MC. Determination of cefepime and cefpirome in human serum by high-performance liquid chromatography using an ultrafiltration for antibiotics serum extraction. J Chromatogr B Biomed Sci Appl. 1999; 734: 121-7
    CrossrefPubMedGoogle Scholar
  • 7 Cherti N, Kinowski JM, Lefrant TY, Bressolle F. High-performance liquid chromatographic determination of cefepime in human plasma and in urine and dialysis fluid using a column-switching technique. J Chromatogr b Biomedl Sci Appl. 2001; 754: 377-86
    PubMedGoogle Scholar
  • 8 Ip M, Au C, Cheung SW, Chan CY, Cheng AF. A rapid high-performance liquid chromatographic assay for cefepime, cefpirome and meropenem. J Antimicrob Chemother. 1998; 42: 121-3
    CrossrefPubMedGoogle Scholar